Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Crescent Capital BDC stock
Learn how to easily invest in Crescent Capital BDC stock.
Crescent Capital BDC Inc is an asset management business based in the US. Crescent Capital BDC shares (CCAP) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Crescent Capital BDC
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CCAP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Crescent Capital BDC stock price (NASDAQ: CCAP)Use our graph to track the performance of CCAP stocks over time.
Crescent Capital BDC shares at a glance
|Latest market close||$15.90|
|52-week range||$14.83 - $19.83|
|50-day moving average||$16.93|
|200-day moving average||$18.12|
|Wall St. target price||$19.63|
|Dividend yield||$1.64 (10.73%)|
|Earnings per share (TTM)||$2.70|
Buy Crescent Capital BDC shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Crescent Capital BDC stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Crescent Capital BDC price performance over time
|1 week (2022-06-30)||2.58%|
|1 month (2022-06-07)||-8.73%|
|3 months (2022-04-07)||-10.52%|
|6 months (2022-01-07)||-11.42%|
|1 year (2021-07-07)||-15.47%|
|2 years (2020-07-07)||23.16%|
|3 years (2019-07-03)||N/A|
|5 years (2017-07-03)||N/A|
Is Crescent Capital BDC stock undervalued or overvalued?
Valuing Crescent Capital BDC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Crescent Capital BDC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Crescent Capital BDC's P/E ratio
Crescent Capital BDC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Crescent Capital BDC shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Crescent Capital BDC's PEG ratio
Crescent Capital BDC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8918. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Crescent Capital BDC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Crescent Capital BDC financials
|Revenue TTM||$99.3 million|
|Operating margin TTM||72.16%|
|Gross profit TTM||$94 million|
|Return on assets TTM||3.74%|
|Return on equity TTM||12.79%|
|Market capitalisation||$482.5 million|
TTM: trailing 12 months
Crescent Capital BDC share dividends
Dividend payout ratio: 54.36% of net profits
Recently Crescent Capital BDC has paid out, on average, around 54.36% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 10.73% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Crescent Capital BDC shareholders could enjoy a 10.73% return on their shares, in the form of dividend payments. In Crescent Capital BDC's case, that would currently equate to about $1.64 per share.
Crescent Capital BDC's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Crescent Capital BDC's most recent dividend payout was on 14 September 2022. The latest dividend was paid out to all shareholders who bought their shares by 31 August 2022 (the "ex-dividend date").
Crescent Capital BDC share price volatility
Over the last 12 months, Crescent Capital BDC's shares have ranged in value from as little as $14.829 up to $19.8303. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Crescent Capital BDC's is 0.9327. This would suggest that Crescent Capital BDC's shares are less volatile than average (for this exchange).
Crescent Capital BDC overview
Crescent Capital BDC, Inc. is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States. .
Crescent Capital BDC in the news
6 Strong Dividend Stocks to Buy for High Inflation
Frequently asked questionsWhat percentage of Crescent Capital BDC is owned by insiders or institutions?
Currently 15.533% of Crescent Capital BDC shares are held by insiders and 55.4% by institutions. When does the fiscal year end for Crescent Capital BDC?
Crescent Capital BDC's fiscal year ends in December. Where is Crescent Capital BDC based?
Crescent Capital BDC's address is: 11100 Santa Monica Boulevard, Los Angeles, CA, United States, 90025 What is Crescent Capital BDC's ISIN number?
Crescent Capital BDC's international securities identification number is: US2256551092 What is Crescent Capital BDC's CUSIP number?
Crescent Capital BDC's Committee on Uniform Securities Identification Procedures number is: 225655109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert